Sri Rao, MBA

Leading U.S. Operations for P&F Medical as we advance the TRICAV II pivotal trial in the United States. This includes close collaboration with investigators, research teams, Meditrial, regulatory leadership, and global management to drive subject enrollment, strengthen site performance, and position the organization for long-term success.

Built and led the U.S. Therapy Development organization, driving clinical adoption and execution for a novel heart failure therapy across a national footprint. • Recruited, developed, and led a national team of 9 Therapy Development Managers supporting 90+ clinical trial sites across the United States. • Drove physician engagement and site activation strategies that accelerated 1500+ subjects enrolled and strengthened investigator relationships nationwide. • Partnered cross-functionally with Clinical, Regulatory, Marketing, and Executive Leadership to align clinical strategy with long-term commercialization goals. • Played a key role in shaping therapy positioning and field strategy to support future commercial launch readiness. • Promoted from Director to Senior Director based on performance, leadership impact, and organizational growth.

Led a national team of 9 Therapy Development Managers, driving clinical engagement, physician education, and site performance across key U.S. regions.

Supported clinical adoption efforts across targeted accounts, partnering with investigators and site teams to drive engagement, enrollment, and protocol execution.

Led a regional sales organization responsible for the Abbott Coronary Intervention & Imaging Technology portfolio across the Great Lakes region. • Managed and developed a high-performing regional sales team driving consistent performance across a complex cardiovascular portfolio. • Executed regional growth strategy across key hospital systems and physician stakeholders. • Partnered with marketing, clinical, and executive leadership to align commercial strategy with product and market conditions. • Strengthened key account relationships across interventional cardiology programs.

Led regional sales strategy for a disruptive atherectomy platform, focused on expanding adoption and redefining competitive positioning in peripheral vascular intervention. • Built and led a regional sales organization during a critical growth phase for the company. • Drove physician adoption through clinical education, case support, and account development. • Developed key opinion leader relationships to support credibility and early adoption. • Helped shape regional go-to-market strategy for a novel technology platform.

Led a team of 10 sales professionals across the Northeast (NYC) region, with responsibility for commercial execution and P&L performance. • Managed regional revenue performance, forecasting, and business planning. • Developed and coached a team of high-performing sales professionals across major academic and health system accounts. • Strengthened strategic relationships across key cardiovascular programs in the New York metro area.